Tokyo Tape
Sign in
← OLBA Healthcare Holdings

Quarterly report · Q2

2689.TEDINET S100SVKV
Period2023-07-01 → 2023-12-31
Filed2024-02-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥57.5bn2023-07-01 → 2023-12-31Cons.Net sales
Revenue¥110.5bn2022-07-01 → 2023-06-30Cons.Net sales (5-year summary)
Revenue¥53.7bn2022-07-01 → 2022-12-31Cons.Net sales
Operating income¥747m2023-07-01 → 2023-12-31Cons.Operating income
Operating income¥854m2022-07-01 → 2022-12-31Cons.Operating income
Ordinary income¥746m2023-07-01 → 2023-12-31Cons.Ordinary income
Ordinary income¥2.2bn2022-07-01 → 2023-06-30Cons.Ordinary income loss (5-year summary)
Ordinary income¥859m2022-07-01 → 2022-12-31Cons.Ordinary income
Profit before tax¥745m2023-07-01 → 2023-12-31Cons.Income before income taxes
Profit before tax¥857m2022-07-01 → 2022-12-31Cons.Income before income taxes
Net income (owners)¥486m2023-07-01 → 2023-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥1.4bn2022-07-01 → 2023-06-30Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥548m2022-07-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income¥486m2023-07-01 → 2023-12-31Cons.Profit loss
Net income¥548m2022-07-01 → 2022-12-31Cons.Profit loss
Total assets¥43.4bnat 2023-12-31Cons.Assets
Total assets¥40.9bnat 2023-06-30Cons.Assets
Total assets¥40.6bnat 2022-12-31Cons.Total assets (5-year summary)
Total liabilities¥33.3bnat 2023-12-31Cons.Liabilities
Total liabilities¥30.6bnat 2023-06-30Cons.Liabilities
Net assets / equity¥10.2bnat 2023-12-31Cons.Net assets
Net assets / equity¥10.3bnat 2023-06-30Cons.Net assets
Net assets / equity¥9.3bnat 2022-12-31Cons.Net assets (5-year summary)
Cash and deposits¥2.9bnat 2023-12-31Cons.Cash and deposits
Cash and deposits¥2.4bnat 2023-06-30Cons.Cash and deposits
Cash & equivalents¥2.9bnat 2023-12-31Cons.Cash and cash equivalents
Cash & equivalents¥2.4bnat 2023-06-30Cons.Cash and cash equivalents
Cash & equivalents¥2.6bnat 2022-12-31Cons.Cash and cash equivalents
Cash & equivalents¥3.1bnat 2022-06-30dCons.Cash and cash equivalents
Operating cash flow−¥146m2023-07-01 → 2023-12-31Cons.Net cash provided by used in operating activities
Operating cash flow−¥660m2022-07-01 → 2023-06-30Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow−¥1.9bn2022-07-01 → 2022-12-31Cons.Net cash provided by used in operating activities
Investing cash flow−¥347m2023-07-01 → 2023-12-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥306m2022-07-01 → 2023-06-30Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥143m2022-07-01 → 2022-12-31Cons.Net cash provided by used in investment activities
Financing cash flow¥1.0bn2023-07-01 → 2023-12-31Cons.Net cash provided by used in financing activities
Financing cash flow¥176m2022-07-01 → 2023-06-30Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥1.5bn2022-07-01 → 2022-12-31Cons.Net cash provided by used in financing activities
EPS (basic)¥81.012023-07-01 → 2023-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥53.162023-10-01 → 2023-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥234.92022-07-01 → 2023-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥91.092022-07-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥49.242022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
Equity ratio23.4%at 2023-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio25.3%at 2023-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio22.9%at 2022-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 38
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-07-01 → 2023-12-31−¥725m
Reconciling Itemsreconcilingrevenue intersegment2023-07-01 → 2023-12-31−¥725m
Reconciling Itemsreconcilingsegment profit2023-07-01 → 2023-12-31−¥76m
jpcrp040300-q2r_E02928-000Care Nursing Goodsreportable segmentrevenue2023-07-01 → 2023-12-31¥1.3bn
jpcrp040300-q2r_E02928-000Care Nursing Goodsreportable segmentrevenue external2023-07-01 → 2023-12-31¥1.3bn
jpcrp040300-q2r_E02928-000Care Nursing Goodsreportable segmentrevenue intersegment2023-07-01 → 2023-12-31¥1m
jpcrp040300-q2r_E02928-000Care Nursing Goodsreportable segmentsegment profit2023-07-01 → 2023-12-31¥102m
jpcrp040300-q2r_E02928-000Medical Equipmentreportable segmentrevenue2023-07-01 → 2023-12-31¥54.3bn
jpcrp040300-q2r_E02928-000Medical Equipmentreportable segmentrevenue external2023-07-01 → 2023-12-31¥53.6bn
jpcrp040300-q2r_E02928-000Medical Equipmentreportable segmentrevenue intersegment2023-07-01 → 2023-12-31¥656m
jpcrp040300-q2r_E02928-000Medical Equipmentreportable segmentsegment profit2023-07-01 → 2023-12-31¥669m
jpcrp040300-q2r_E02928-000SPDreportable segmentrevenue2023-07-01 → 2023-12-31¥2.6bn
jpcrp040300-q2r_E02928-000SPDreportable segmentrevenue external2023-07-01 → 2023-12-31¥2.5bn
jpcrp040300-q2r_E02928-000SPDreportable segmentrevenue intersegment2023-07-01 → 2023-12-31¥68m
jpcrp040300-q2r_E02928-000SPDreportable segmentsegment profit2023-07-01 → 2023-12-31¥52m
Total Of Reportable Segments And Otherssegment totalrevenue2023-07-01 → 2023-12-31¥58.2bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-07-01 → 2023-12-31¥57.5bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-07-01 → 2023-12-31¥725m
Total Of Reportable Segments And Otherssegment totalsegment profit2023-07-01 → 2023-12-31¥823m
Reconciling Itemsreconcilingrevenue2022-07-01 → 2022-12-31−¥789m
Reconciling Itemsreconcilingrevenue intersegment2022-07-01 → 2022-12-31−¥789m
Reconciling Itemsreconcilingsegment profit2022-07-01 → 2022-12-31−¥71m
jpcrp040300-q2r_E02928-000Care Nursing Goodsreportable segmentrevenue2022-07-01 → 2022-12-31¥1.2bn
jpcrp040300-q2r_E02928-000Care Nursing Goodsreportable segmentrevenue external2022-07-01 → 2022-12-31¥1.2bn
jpcrp040300-q2r_E02928-000Care Nursing Goodsreportable segmentrevenue intersegment2022-07-01 → 2022-12-31¥104,000
jpcrp040300-q2r_E02928-000Care Nursing Goodsreportable segmentsegment profit2022-07-01 → 2022-12-31¥92m
jpcrp040300-q2r_E02928-000Medical Equipmentreportable segmentrevenue2022-07-01 → 2022-12-31¥50.7bn
jpcrp040300-q2r_E02928-000Medical Equipmentreportable segmentrevenue external2022-07-01 → 2022-12-31¥50.0bn
jpcrp040300-q2r_E02928-000Medical Equipmentreportable segmentrevenue intersegment2022-07-01 → 2022-12-31¥726m
jpcrp040300-q2r_E02928-000Medical Equipmentreportable segmentsegment profit2022-07-01 → 2022-12-31¥735m
jpcrp040300-q2r_E02928-000SPDreportable segmentrevenue2022-07-01 → 2022-12-31¥2.6bn
jpcrp040300-q2r_E02928-000SPDreportable segmentrevenue external2022-07-01 → 2022-12-31¥2.5bn
jpcrp040300-q2r_E02928-000SPDreportable segmentrevenue intersegment2022-07-01 → 2022-12-31¥64m
jpcrp040300-q2r_E02928-000SPDreportable segmentsegment profit2022-07-01 → 2022-12-31¥98m
Total Of Reportable Segments And Otherssegment totalrevenue2022-07-01 → 2022-12-31¥54.5bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-07-01 → 2022-12-31¥53.7bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-07-01 → 2022-12-31¥789m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-07-01 → 2022-12-31¥925m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 493
ItemContextValueUnit
Treasury stockPrior1YearInstant-342042000JPY
Treasury stockCurrentQuarterInstant-557173000JPY
Shareholders equityPrior1YearInstant10003715000JPY
Shareholders equityCurrentQuarterInstant9838632000JPY
Valuation difference on available for sale securitiesPrior1YearInstant137135000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant139744000JPY
Remeasurements of defined benefit plansPrior1YearInstant186792000JPY
Remeasurements of defined benefit plansCurrentQuarterInstant176914000JPY
Valuation and translation adjustmentsPrior1YearInstant323927000JPY
Valuation and translation adjustmentsCurrentQuarterInstant316659000JPY
Non controlling interestsPrior1YearInstant－JPY
Non controlling interestsCurrentQuarterInstant－JPY
Net assetsPrior1YearInstant10327643000JPY
Net assetsCurrentQuarterInstant10155291000JPY
Liabilities and net assetsPrior1YearInstant40878181000JPY
Liabilities and net assetsCurrentQuarterInstant43446880000JPY
Net salesPrior1YTDDuration53718093000JPY
Net salesCurrentYTDDuration57466305000JPY
Cost of salesPrior1YTDDuration47535917000JPY
Cost of salesCurrentYTDDuration51035427000JPY
Gross profitPrior1YTDDuration6182175000JPY
Gross profitCurrentYTDDuration6430878000JPY
Selling general and administrative expensesPrior1YTDDuration5328089000JPY
Selling general and administrative expensesCurrentYTDDuration5683979000JPY
Operating incomePrior1YTDDuration854086000JPY
Operating incomeCurrentYTDDuration746899000JPY
Interest income noiPrior1YTDDuration191000JPY
Interest income noiCurrentYTDDuration1119000JPY
Dividends income noiPrior1YTDDuration912000JPY
Dividends income noiCurrentYTDDuration1056000JPY
Insurance income noiPrior1YTDDuration376000JPY
Insurance income noiCurrentYTDDuration483000JPY
Commission fee noiPrior1YTDDuration2495000JPY
Commission fee noiCurrentYTDDuration841000JPY
Electricity sale income noiPrior1YTDDuration5087000JPY
Electricity sale income noiCurrentYTDDuration5130000JPY
Subsidy income noi bountyPrior1YTDDuration6320000JPY
Subsidy income noi bountyCurrentYTDDuration2895000JPY
Other noiPrior1YTDDuration3042000JPY
Other noiCurrentYTDDuration7720000JPY
Non operating incomePrior1YTDDuration18425000JPY
Non operating incomeCurrentYTDDuration19246000JPY
Interest expenses noePrior1YTDDuration9222000JPY
Interest expenses noeCurrentYTDDuration9798000JPY
Electricity sale expenses noePrior1YTDDuration2465000JPY
Electricity sale expenses noeCurrentYTDDuration2287000JPY
Other noePrior1YTDDuration1494000JPY
Other noeCurrentYTDDuration7921000JPY
Non operating expensesPrior1YTDDuration13181000JPY
Non operating expensesCurrentYTDDuration20006000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2023-06-30pass
balance sheet identityconsolidated 2023-12-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-06-30pass
statement vs summary · net assetsconsolidated 2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-07-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-07-01/2023-12-31pass
statement vs summary · operating cash flowconsolidated 2022-07-01/2022-12-31pass
statement vs summary · operating cash flowconsolidated 2023-07-01/2023-12-31pass
statement vs summary · revenueconsolidated 2022-07-01/2022-12-31pass
statement vs summary · revenueconsolidated 2023-07-01/2023-12-31pass
statement vs summary · total assetsconsolidated 2023-06-30pass
statement vs summary · total assetsconsolidated 2023-12-31pass